Protein Polymer Technologies, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Protein Polymer Technologies, Inc. makes
Protein Polymer Technologies, Inc. manufactures embolic particles for vascular occlusion, including PVA-based foam embolic particles such as Modified PVA-Plus, MaxiStat PVA, and MicroStat PVA. These products are designed for interventional radiology procedures to treat vascular abnormalities like arteriovenous malformations or tumors by blocking blood flow.
The company’s embolic particles are classified as Class II medical devices under FDA regulations and are supported by 510(k) clearance records. The portfolio is listed in the FDA’s 510(k) database, reflecting their regulatory authorization in the United States.
Catalogue
Modified Pva-Plus Foam Embolization Particles And Maxistat And Microstat Pva Foam Embolization Particles Ref K053548
Regimes: 510(k) Registry: 510(k)- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Protein Polymer Technologies, Inc. have in the registry?
The registry currently lists 2 devices for Protein Polymer Technologies, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Protein Polymer Technologies, Inc.'s devices?
Among its 2 most recently registered devices, Protein Polymer Technologies, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Protein Polymer Technologies, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Protein Polymer Technologies, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Protein Polymer Technologies, Inc. in the registry?
The most recently registered devices listed for Protein Polymer Technologies, Inc. include MODIFIED PVA-PLUS FOAM EMBOLIZATION PARTICLES AND MAXISTAT AND MICROSTAT PVA FOAM EMBOLIZATION PARTICLES and PVA PLUS, MAXISTAT PVA, MICROSTAT PVA FOAM EMBOLIZATION PARTICLES.